|
FR2505657A1
(fr)
|
1981-05-13 |
1982-11-19 |
Pasteur Institut |
Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation
|
|
US5626851A
(en)
|
1987-11-30 |
1997-05-06 |
The Wistar Institute Of Anatomy And Biology |
Rotavirus reassortant vaccine
|
|
US5096885A
(en)
|
1988-04-15 |
1992-03-17 |
Genentech, Inc. |
Human growth hormone formulation
|
|
DE69029765T2
(de)
|
1989-07-24 |
1997-05-15 |
Bayer Ag |
Stabilisierung von hochgereinigten Proteinen
|
|
CA2132328C
(en)
|
1992-03-24 |
2000-10-31 |
Laszlo K. Csatary |
Vaccine containing live virus for therapy of viral diseases and malignancies
|
|
CA2075521C
(en)
|
1992-05-05 |
1995-11-28 |
Kuniaki Koyama |
Stabilized live vaccine
|
|
JPH09504429A
(ja)
|
1993-10-12 |
1997-05-06 |
チロン ビアジーン，インコーポレイティド |
組換えウイルスの保存方法
|
|
JP3863559B2
(ja)
|
1994-05-16 |
2006-12-27 |
メルク エンド カンパニー インコーポレーテッド |
乳頭腫ウィルスワクチン
|
|
US7150984B2
(en)
|
1994-07-11 |
2006-12-19 |
The United States Of America As Represented By The Department Of Health And Human Services |
Attenuated human rotavirus vaccine
|
|
US6586006B2
(en)
|
1994-08-04 |
2003-07-01 |
Elan Drug Delivery Limited |
Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
|
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
|
US6267958B1
(en)
|
1995-07-27 |
2001-07-31 |
Genentech, Inc. |
Protein formulation
|
|
US6685940B2
(en)
|
1995-07-27 |
2004-02-03 |
Genentech, Inc. |
Protein formulation
|
|
CA2226575C
(en)
|
1995-07-27 |
2011-10-18 |
Genentech, Inc. |
Stabile isotonic lyophilized protein formulation
|
|
GB9521806D0
(en)
|
1995-10-25 |
1996-01-03 |
Cortecs Ltd |
Preservation methods
|
|
US6165773A
(en)
|
1995-10-25 |
2000-12-26 |
Provalis Uk Limited |
Methods of preserving viruses
|
|
FR2742756B1
(fr)
|
1995-12-22 |
1998-04-03 |
Pasteur Merieux Serums Vacc |
Stabilisants pour vaccins vivants, vaccins les contenant et procedes pour leur preparation
|
|
FR2751343B1
(fr)
|
1996-07-16 |
1998-12-18 |
Transgene Sa |
Procede de conservation de virus recombinants infectieux, suspension aqueuse virale et utilisation comme medicament
|
|
US5932223A
(en)
*
|
1996-09-26 |
1999-08-03 |
Merck & Co., Inc. |
Rotavirus vaccine formulations
|
|
US6403098B1
(en)
|
1996-09-26 |
2002-06-11 |
Merck & Co., Inc. |
Rotavirus vaccine formulations
|
|
EP0939648B1
(en)
|
1996-09-26 |
2007-11-07 |
Merck & Co., Inc. |
Rotavirus vaccine formulations
|
|
US6616931B1
(en)
|
1996-09-26 |
2003-09-09 |
Merck & Co., Inc. |
Rotavirus vaccine formulations
|
|
US7732129B1
(en)
|
1998-12-01 |
2010-06-08 |
Crucell Holland B.V. |
Method for the production and purification of adenoviral vectors
|
|
US6544769B1
(en)
|
1996-12-13 |
2003-04-08 |
Schering Corporation |
Compostions comprising viruses and methods for concentrating virus preparations
|
|
US20080261289A1
(en)
|
1996-12-13 |
2008-10-23 |
Schering-Plough Corporation |
Compositions comprising viruses and methods for concentrating virus preparations
|
|
JP2000507963A
(ja)
|
1996-12-20 |
2000-06-27 |
メルク エンド カンパニー インコーポレーテッド |
凍結乾燥ワクチン用安定剤
|
|
US6290967B1
(en)
|
1996-12-20 |
2001-09-18 |
Merck & Co., Inc. |
Stabilizers for lyophilized vaccines
|
|
US6051238A
(en)
|
1996-12-20 |
2000-04-18 |
Merck & Co., Inc. |
Stabilizers for lyophilized mumps vaccines
|
|
US6565831B1
(en)
*
|
1999-02-24 |
2003-05-20 |
Oncolytics Biotech Inc. |
Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
|
|
KR100912362B1
(ko)
|
1998-02-17 |
2009-08-19 |
쉐링 코포레이션 |
바이러스 제제의 정제방법
|
|
GB9808922D0
(en)
|
1998-04-24 |
1998-06-24 |
Cantab Pharmaceuticals Res Ltd |
Virus preparations
|
|
CN101318016B
(zh)
|
1998-07-28 |
2013-06-19 |
由卫生与公众服务部代表的美利坚合众国 |
多价人-牛轮状病毒疫苗
|
|
CN1062770C
(zh)
*
|
1998-11-12 |
2001-03-07 |
卫生部长春生物制品研究所 |
甲肝-麻疹二联疫苗及其生产方法
|
|
DE69940354D1
(de)
|
1998-11-16 |
2009-03-12 |
Introgen Therapeutics Inc |
Adenovirus-formulierungen zur gentherapie
|
|
US6689600B1
(en)
*
|
1998-11-16 |
2004-02-10 |
Introgen Therapeutics, Inc. |
Formulation of adenovirus for gene therapy
|
|
US6225289B1
(en)
|
1998-12-10 |
2001-05-01 |
Genvec, Inc. |
Methods and compositions for preserving adenoviral vectors
|
|
WO2000061184A2
(en)
|
1999-04-08 |
2000-10-19 |
Glenn Gregory M |
Dry formulation for transcutaneous immunization
|
|
PL364983A1
(en)
|
1999-08-24 |
2004-12-27 |
Teva Pharmaceutical Industries, Ltd. |
A vaccine composition and method of using the same
|
|
US6592869B2
(en)
|
1999-08-24 |
2003-07-15 |
Teva Pharmaceutical Industries, Ltd. |
Vaccine composition and method of using the same
|
|
DE60025019T2
(de)
|
1999-10-29 |
2006-08-24 |
Nektar Therapeutics, San Carlos |
Trockenpulverzusammensetzungen mit verbesserter dispersivität
|
|
EP2420247A1
(en)
|
2000-03-07 |
2012-02-22 |
Merck Sharp & Dohme Corp. |
Adenovirus formulations
|
|
US7456009B2
(en)
*
|
2000-03-07 |
2008-11-25 |
Merck & Co., Inc. |
Adenovirus formulations
|
|
US20020120228A1
(en)
|
2000-06-08 |
2002-08-29 |
Yuh-Fun Maa |
Powder compositions
|
|
EP1289494A2
(en)
|
2000-06-08 |
2003-03-12 |
Powderject Vaccines, Inc. |
Powder compositions
|
|
US6689353B1
(en)
*
|
2000-06-28 |
2004-02-10 |
Bayer Pharmaceuticals Corporation |
Stabilized interleukin 2
|
|
TWI289158B
(en)
|
2000-08-10 |
2007-11-01 |
Oncolytics Biotech Inc |
Method of producing infectious reovirus
|
|
GB0020089D0
(en)
|
2000-08-15 |
2000-10-04 |
Smithkline Beecham Biolog |
Vaccine Composition
|
|
US7494659B2
(en)
|
2000-09-25 |
2009-02-24 |
Polymun Scientific Immunbiologische Forschung Gmbh |
Live attenuated influenza vaccine
|
|
US20040033239A1
(en)
|
2001-03-06 |
2004-02-19 |
Evans Robert K |
Adenovirus formulations
|
|
DK2253701T3
(da)
|
2001-03-16 |
2014-10-20 |
Oncolytics Biotech Inc |
Fremgangsmåde til ekstraktion af en virus fra en cellekultur
|
|
CA2449593A1
(en)
|
2001-06-08 |
2002-12-19 |
Powderject Vaccines, Inc. |
Spray freeze-dried compositions
|
|
GB0124710D0
(en)
|
2001-10-15 |
2001-12-05 |
Quadrant Healthcare Uk Ltd |
Therapeutic composition
|
|
CN1607941A
(zh)
|
2001-11-19 |
2005-04-20 |
贝克顿迪肯森公司 |
粒状药物组合物
|
|
EP1453536A4
(en)
|
2001-12-12 |
2009-08-26 |
Mayne Pharma Int Pty Ltd |
COMPOSITION FOR PRESERVING VIRUSES
|
|
US20030153065A1
(en)
|
2002-01-14 |
2003-08-14 |
Genvec, Inc. |
Composition and method for maintaining non-enveloped viral vectors
|
|
AR038153A1
(es)
|
2002-01-18 |
2004-12-29 |
Schering Ag |
Formulaciones estabilizadas de adenovirus
|
|
US7135180B2
(en)
|
2002-04-11 |
2006-11-14 |
Medimmune Vaccines, Inc. |
Preservation of bioactive materials by freeze dried foam
|
|
US7923029B2
(en)
|
2002-04-11 |
2011-04-12 |
Medimmune Llc |
Spray freeze dry of compositions for pulmonary administration
|
|
WO2003086443A1
(en)
|
2002-04-11 |
2003-10-23 |
Medimmune Vaccines, Inc. |
Spray freeze dry of compositions for intranasal administration
|
|
CA2482512C
(en)
|
2002-04-30 |
2011-09-20 |
Oncolytics Biotech Inc. |
Improved viral purification methods
|
|
EP2395073B1
(en)
|
2002-11-01 |
2017-09-06 |
GlaxoSmithKline Biologicals S.A. |
Drying process
|
|
US6752740B2
(en)
|
2002-11-12 |
2004-06-22 |
Jeffery T. Semmes |
Continuously variable transmission
|
|
KR20050088175A
(ko)
|
2002-12-17 |
2005-09-02 |
메드이뮨 백신즈 인코포레이티드 |
생물활성 물질의 고압 분무 건조
|
|
US6931888B2
(en)
|
2003-02-07 |
2005-08-23 |
Ferro Corporation |
Lyophilization method and apparatus for producing particles
|
|
ES2529736T3
(es)
|
2003-04-10 |
2015-02-25 |
Novartis Vaccines And Diagnostics, Inc. |
Composición inmunogénica que comprende una proteína espicular del coronavirus del SARS
|
|
EP1660123B1
(en)
|
2003-09-02 |
2013-03-13 |
GlaxoSmithKline Biologicals s.a. |
Rotavirus vaccine
|
|
US20070148765A1
(en)
|
2003-11-19 |
2007-06-28 |
Evans Robert K |
Preservative-containing virus formulations
|
|
EP1701738B1
(en)
|
2003-12-17 |
2015-03-11 |
Wyeth LLC |
Method for producing storage stable RSV compositions
|
|
WO2005066333A1
(en)
|
2003-12-30 |
2005-07-21 |
Aventis Pasteur, Inc. |
Stabilizing compositions for recombinant viruses
|
|
GB0404586D0
(en)
|
2004-03-01 |
2004-04-07 |
Britannia Pharmaceuticals Ltd |
Improvements in or relating to organic materials
|
|
EP1720519A1
(en)
|
2004-03-04 |
2006-11-15 |
Wyeth |
Lyophilization method to improve excipient crystallization
|
|
ES2644416T3
(es)
|
2004-06-02 |
2017-11-28 |
Universal Stabilization Technologies, Inc. |
Conservación mediante vaporización
|
|
WO2006029467A1
(en)
|
2004-09-16 |
2006-03-23 |
Btf Pty Ltd |
Rapid freeze drying process
|
|
TW200626177A
(en)
|
2004-09-28 |
2006-08-01 |
Alza Corp |
Method and formulation for stabilizing alum-adsorbed vaccines
|
|
JP5147405B2
(ja)
*
|
2004-10-06 |
2013-02-20 |
メディミューン，エルエルシー |
冷蔵温度安定型インフルエンザワクチン組成物
|
|
US7901921B2
(en)
|
2004-10-22 |
2011-03-08 |
Oncolytics Biotech Inc. |
Viral purification methods
|
|
MX2007005379A
(es)
*
|
2004-11-05 |
2007-07-04 |
Wellstat Biologics Corp |
Formulaciones de virus envueltos estables y filtrables.
|
|
ATE406140T1
(de)
|
2004-12-09 |
2008-09-15 |
Precimed Sa |
Operationsinstrumentenhalter für leichtere sterilisation
|
|
US20060141483A1
(en)
*
|
2004-12-23 |
2006-06-29 |
Calton Gary J |
Stabilization of viral compositions
|
|
SI1853250T1
(sl)
*
|
2005-02-18 |
2012-01-31 |
Abraxis Bioscience Llc |
Kombinacije in reĹľimi dajanja terapevtskih sredstev in kombinirana terapija
|
|
PT1954308E
(pt)
*
|
2005-09-16 |
2011-11-03 |
Merial Ltd |
Estabilizadores para vacinas liofilizadas
|
|
CN1765181A
(zh)
|
2005-10-19 |
2006-05-03 |
路兴波 |
高效抗病毒制剂
|
|
PL2007883T3
(pl)
|
2006-04-20 |
2012-07-31 |
Wyeth Llc |
Sposób oczyszczania do izolacji oczyszczonego wirusa pęcherzykowatego zapalenia jamy ustnej z hodowli komórkowej
|
|
US9283260B2
(en)
|
2006-04-21 |
2016-03-15 |
Amgen Inc. |
Lyophilized therapeutic peptibody formulations
|
|
EP1854478A1
(en)
|
2006-05-12 |
2007-11-14 |
Cytos Biotechnology AG |
Nicotine-carrier vaccine formulation
|
|
EP1878791A1
(en)
|
2006-07-11 |
2008-01-16 |
Bia Separations D.O.O. |
Method for influenza virus purification
|
|
EP2055311B1
(en)
|
2006-08-07 |
2017-06-21 |
The Chemo-Sero-Therapeutic Research Institute |
Process for preparing live smallpox vaccine
|
|
US20100129379A1
(en)
|
2006-09-25 |
2010-05-27 |
John Carpenter |
Stabilized antibody formulations and uses thereof
|
|
NZ576563A
(en)
|
2006-11-03 |
2012-09-28 |
Alphavax Inc |
Alphavirus and alphavirus replicon particle formulations and methods
|
|
CL2007003209A1
(es)
*
|
2006-11-07 |
2008-05-09 |
Acambis Inc |
Composicion que comprende una vacuna de flavivirus vivos atenuados; composicion que comprende un producto farmaceutico derivado de virus o proteina; un metodo para la elaboracion de una composicion terapeutica que comprende liofilizar las composicion
|
|
EP2762163B1
(en)
*
|
2006-12-27 |
2018-01-03 |
Zoetis Services LLC |
Methods of vaccine administration
|
|
US20080299182A1
(en)
|
2007-03-01 |
2008-12-04 |
Shuyuan Zhang |
Methods and formulations for topical gene therapy
|
|
JP5577103B2
(ja)
*
|
2007-03-12 |
2014-08-20 |
オンコリティクス バイオテク，インコーポレーテッド |
改変配列を有するレオウイルス
|
|
GB0705245D0
(en)
|
2007-03-19 |
2007-04-25 |
Stabilitech Ltd |
Stable biological products
|
|
CA2681567C
(en)
|
2007-03-22 |
2016-07-19 |
The Regents Of The University Of Colorado, A Body Corporate |
Method of preparing an immunologically-active adjuvant-bound dried vaccine composition
|
|
EP2940129B1
(en)
|
2007-04-06 |
2020-05-06 |
Takeda Vaccines, Inc. |
Methods and compositions for live attenuated viruses
|
|
AR066649A1
(es)
|
2007-05-21 |
2009-09-02 |
Oncolytics Biotech Inc |
Reovirus mutantes y metodos de elaboracion y uso de los mismos
|
|
US8241886B2
(en)
*
|
2007-09-25 |
2012-08-14 |
Aridis Pharmaceuticals |
Formulations for preservation of rotavirus
|
|
EP2630966B1
(en)
*
|
2007-10-12 |
2017-04-19 |
Massachusetts Institute of Technology |
Vaccine nanotechnology
|
|
WO2009056651A1
(en)
|
2007-11-02 |
2009-05-07 |
Cytos Biotechnology Ag |
Angiotensin-carrier formulation
|
|
NZ585500A
(en)
|
2007-11-12 |
2012-06-29 |
Theraclone Sciences Inc |
Antibodies which bind to an epitope in the extracellular domain of the matrix 2 ectodomain polypeptide of an influenza virus
|
|
US8227577B2
(en)
|
2007-12-21 |
2012-07-24 |
Hoffman-La Roche Inc. |
Bivalent, bispecific antibodies
|
|
JP2011514337A
(ja)
|
2008-02-25 |
2011-05-06 |
ノババックス，インコーポレイテッド |
糖ガラス化ウィルス様粒子（ｖｌｐ）
|
|
WO2009133413A1
(en)
*
|
2008-04-28 |
2009-11-05 |
Novatech D.O.O. |
Formulation based on micronized clinoptilolite as a therapeutic agent for removal of toxins, bacteria and viruses from organism
|
|
WO2011026948A1
(en)
*
|
2009-09-03 |
2011-03-10 |
Ablynx N.V. |
Stable formulations of polypeptides and uses thereof
|
|
AU2011336413B2
(en)
|
2010-12-02 |
2015-01-22 |
Oncolytics Biotech Inc. |
Liquid viral formulations
|
|
MX349294B
(es)
*
|
2010-12-02 |
2017-07-21 |
Oncolytics Biotech Inc |
Formulaciones virales liofilizadas.
|
|
JP6029651B2
(ja)
*
|
2011-04-29 |
2016-11-24 |
オンコリティクス バイオテク，インコーポレーテッド |
ゲル浸透クロマトグラフィーを使用してウイルスを精製する方法
|
|
JP6065096B2
(ja)
|
2015-12-25 |
2017-01-25 |
ダイキン工業株式会社 |
調湿装置
|